CAMP4 Therapeutics (NASDAQ: CAMP) revenue
CAMP4 Therapeutics reported revenue of $3.5m for fiscal 2025, 436.5% more than in fiscal 2024 ($0.7m). Since fiscal 2023 its revenue has grown by 899.4%, an average growth of 216.1% a year.
CAMP4 Therapeutics has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 3 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $3.5m | +436.5% | −$52.6m | −1,502.4% |
| 2024 | $0.7m | +86.3% | −$53.1m | −8,142.3% |
| 2023 | $0.4m | — | −$51.9m | −14,822.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
CAMP4 Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, CAMP4 Therapeutics ranks 386th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; CAMP4 Therapeutics, 436.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 384th | CG Oncology | $4.0m | 254.7% |
| 385th | Crispr Therapeutics AG | $3.5m | −90.6% |
| 386th | CAMP4 Therapeutics | $3.5m | 436.5% |
| 387th | Surrozen | $3.5m | −67.4% |
| 388th | Onkure Therapeutics | $3.4m | 70.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of CAMP4 Therapeutics
- How much revenue did CAMP4 Therapeutics make in fiscal 2025?
- CAMP4 Therapeutics reported revenue of $3.5m for fiscal 2025, compared with $0.7m in fiscal 2024.
- How much has the revenue of CAMP4 Therapeutics grown?
- Between fiscal 2023 and fiscal 2025 it went from $0.4m to $3.5m: 899.4% more, an average growth of 216.1% a year.
- What was the best year for revenue at CAMP4 Therapeutics?
- Of its last 3 fiscal years, fiscal 2025, with $3.5m.
- Where does CAMP4 Therapeutics rank in its sector by revenue?
- It ranks 386th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for CAMP4 Therapeutics come from?
- From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on CAMP4 Therapeutics: the CAMP4 Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.